Nuvaxovid COVID-19 Vaccine Wins EU Approval
Data On Efficacy Of Nuvaxovid Against Omicron Is Limited
Initial doses of Novavax’s vaccine are expected to arrive in Europe in January.
Initial doses of Novavax’s vaccine are expected to arrive in Europe in January.